Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Onome T Abiri"'
Autor:
Innocent Nuwagira, Sulaiman Lakoh, Zikan Koroma, James Baligeh Walter Russell, Sia Morenike Tengbe, Ibrahim Franklyn Kamara, Joseph Kanu, Anna Maruta, Bobson Derrick Fofanah, Kadijatu Nabie Kamara, Bockarie Sheriff, Victoria Katawera, Selassi A D'Almeida, Robert Musoke, Rugiatu Z Kamara, Abdul Razak Mansaray, Fawzi Thomas, Onome T Abiri, Aminata Tigiedankay Koroma, James Squire, Mohamed Alex Vandi
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Objective Inappropriate use of antibiotics is a major driver of antibiotic resistance. A few studies conducted in Africa have documented that about half of hospitalised patients who receive antibiotics should not have received them. A few hospital-ba
Externí odkaz:
https://doaj.org/article/8e7fafe26f2d4a94922afbbe48ef4bea
Autor:
Solomon Owusu Sekyere, Ivana Škrnjug-Yudov, Ulysse Ateba Ngoa, Marcela Juárez Hernández, Onome T. Abiri, James P. Komeh, Markieu Janneh Kaira, Essa Marenah, Juwe Darnuwele Kercula, Keturah Smith, Olga Rassokhina, Heidi Meyer, Christoph Conrad
Publikováno v:
Globalization and Health, Vol 18, Iss 1, Pp 1-13 (2022)
Abstract Background A stable, well-functioning and integrated national medicines regulatory system is a core component of health systems resilient against infectious disease outbreaks. In many low- and middle-income countries, however, sizable gaps e
Externí odkaz:
https://doaj.org/article/eb56c75245c1455490fca7e8357f3925
Autor:
Onome T. Abiri, Abdulai J. Bah, Michael Lahai, Durodami R. Lisk, James P. Komeh, Joy Johnson, Wiltshire C. N. Johnson, Sheku S. Mansaray, Joseph Sam Kanu, James B. W. Russell, Fawzi Thomas, Murtada M. Sesay, Thomas A. Conteh, Alphan Tejan-Kella, Mohamed Sesay, Manal Ghazzawi, Brian Thompson, Sorie Conteh, Gibrilla Fadlu Deen
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Clinical trials during public health emergencies of novel medical products such as therapeutics and vaccines in resource-limited settings are daunting due to the limited capacity for regulatory assessment. Regulating clinical trials during t
Externí odkaz:
https://doaj.org/article/ee5d2605c278459a9594dbd0606eddd6
Autor:
Thomas A. Conteh, Fawzi Thomas, Onome T. Abiri, James P. Komeh, Abdulai Kanu, Joseph Sam Kanu, Bobson Derrick Fofanah, Pruthu Thekkur, Rony Zachariah
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 8, Iss 10, p 470 (2023)
Background: The quality of pharmacovigilance data is important for guiding medicine safety and clinical practice. In baseline and follow-up studies after introducing interventions to improve the quality of reporting of Individual Case Safety Reports
Externí odkaz:
https://doaj.org/article/d837ea29fff64583b8e61aa538cc65ce
Autor:
Sulaiman Lakoh, Valerie John-Cole, Ronita D.C. Luke, Nellie Bell, James B.W. Russell, Ayeshatu Mustapha, Umu Barrie, Onome T. Abiri, Joshua M. Coker, Matilda N. Kamara, Freddie J. Coker, Olukemi Adekanmbi, Ibrahim Franklyn Kamara, Bobson Derrick Fofanah, Darlinda F. Jiba, Adetunji O. Adeniji, Sartie Kenneh, Gibrilla F. Deen, Troy D. Moon, George A. Yendewa, Emmanuel Firima
Publikováno v:
IJID Regions. 7:43-51
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 12, Iss 1 (2019)
Few low and middle-income countries (LMIC) have fully operational pharmacovigilance structures, systems and legal framework to collect and collate safety data and evaluate the risks and benefits by active and passive approaches. However, in a LMIC su
Externí odkaz:
https://doaj.org/article/a59479f3beba4edb9476cbb1b8ded26e
Autor:
Fawzi Thomas, Onome T. Abiri, James P. Komeh, Thomas A. Conteh, Abdulai Jawo Bah, Joseph Sam Kanu, Robert Terry, Arpine Abrahamyan, Pruthu Thekkur, Rony Zachariah
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 6; Pages: 3264
Background: Monitoring of adverse drug reactions (ADRs) to antimicrobials is important, as they can cause life-threatening illness, permanent disabilities, and death. We assessed country-wide ADR reporting on antimicrobials and their outcomes. Method
Autor:
Onome T. Abiri, Abdulai J. Bah, Michael Lahai, Durodami R. Lisk, James P. Komeh, Joy Johnson, Wiltshire C. N. Johnson, Sheku S. Mansaray, Joseph Sam Kanu, James B. W. Russell, Fawzi Thomas, Murtada M. Sesay, Thomas A. Conteh, Alphan Tejan-Kella, Mohamed Sesay, Manal Ghazzawi, Brian Thompson, Sorie Conteh, Gibrilla Fadlu Deen
Publikováno v:
Trials. 23(1)
Clinical trials during public health emergencies of novel medical products such as therapeutics and vaccines in resource-limited settings are daunting due to the limited capacity for regulatory assessment. Regulating clinical trials during the Ebola
Autor:
Onome T. Abiri, Mohamed Sesay, Anthony D. Harries, Bailah Molleh, Wenjing Tao, Shuwary Barlatt, Mohammed Khogali, Collins Timire, Katrina Hann, Hannock Tweya, Anna Maruta, James P. Komeh, Ahmed Sankoh-Hughes, Joseph Sam Kanu, Mohamed A. Vandi, Joy Johnson, Fawzi Thomas
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 6, Iss 77, p 77 (2021)
Tropical Medicine and Infectious Disease
Volume 6
Issue 2
Tropical Medicine and Infectious Disease
Volume 6
Issue 2
Monitoring antibiotic consumption is crucial to tackling antimicrobial resistance. However, currently there is no system in Sierra Leone for recording and reporting on antibiotic consumption. We therefore conducted a cross-sectional study to assess n
Autor:
Michael Lahai, Laurie Lake, Ahmed Vandy, Bondu Sebba, Mohamed Sesay, Onome T. Abiri, Joy Johnson, Tamba Buffa, Abdulai Kanu, Mohamed Bawoh, James P. Komeh, Wiltshire C.N Johnson
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background National Medicines Regulatory Authorities like the Pharmacy Board of Sierra Leone are responsible for protecting and promoting public health, implementing regulatory standards, and maintaining a supply chain with an assured supply
Externí odkaz:
https://doaj.org/article/96c97a51e7e340debf4c14f40958f1db